Resent articles by the "Worldwide Biotech" from The Free Libraryhttp://www.thefreelibrary.comen-usFarlex, Inc.Thu, 10 Dec 2009 15:21:38 GMT360http://www.thefreelibrary.comhttp://www.thefreelibrary.com/_/static/TFLbyFarlex.gif17565Tue, 1 Dec 2009 00:00:00 http://www.thefreelibrary.com/ACM+GLOBAL+CENTRAL+LAB+CELEBRATES+10+YRS+OF+PROVIDING+SERVIVES.-a0213074130
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach,

The European arm of ACM Global Central Laboratory, based in York, England, initiated as Pivotal Laboratories Limited in 1999 and since then has significantly expanded from a small scale operation to providing clinical trial services for...]]>Tue, 1 Dec 2009 00:00:00 http://www.thefreelibrary.com/CUMBERLAND%2fPHEBRA+PTY+LTD.+TO+COMMERCIALIZE+CALDOLOR.-a0213074129
Nashville, Tenn., (October 29, 2009) - Cumberland Pharmaceuticals Inc. (Nasdaq:CPIX) and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor(r) (ibuprofen) Injection in Australia and New Zealand. An intravenous formulation of ibuprofen, Caldolor is designed to treat...]]>Tue, 1 Dec 2009 00:00:00 http://www.thefreelibrary.com/COMPUGEN+PRESENTS+DAC+BLOCKERS+PLATFORM%2fINITIAL+PRODUCT+CANDIDATES.-a0213074128
Speaking in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. (NASDAQ: CGEN) project manager Dr. Yossef Kliger provided an overview of Compugen's DAC Blockers Platform and reviewed disease model data for selected product candidates. Among the product candidates reviewed were targets belonging to the Heat Shock Protein family, currently a key area of focus for...]]>Tue, 1 Dec 2009 00:00:00 http://www.thefreelibrary.com/HEALTHLINX+CONFIRMS+COLLABORATORS+FOR+OVPLEX+OVARIAN+CANCER+STUDY.-a0213074127
Melbourne: HealthLinx Limited (ASX:HTX) has confirmed its collaborators who will work with the company on its second larger OvPlex(tm) ovarian cancer diagnostic trial. The trial using 1150 samples will take place in Australia, Singapore and the UK and include:

* Professor Lewis Perrin, director of Gynaecological Oncology at Mater Hospital, Brisbane, Australia

...]]>Sun, 1 Nov 2009 00:00:00 http://www.thefreelibrary.com/STEMCELLS%2c+INC.+TO+ADVANCE+CELL-BASED+TECHNOLOGIES.-a0210142893
StemCells, Inc. (NASDAQ: STEM). Palo Alto, Calif., has announced organizational initiatives focused on growing its specialty SC ProvenR cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the company's ongoing integration...]]>Sun, 1 Nov 2009 00:00:00 http://www.thefreelibrary.com/METHYLGENE+TO+RESUME+DEVELOPMENT+OF+MGCD0103+(MOCETINOSTAT).-a0210142892
MethylGene Inc. (TSX:MYG), Montreal, Quebec. has announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold placed on MGCD0103, the company's proprietary selective histone deacetylase (HDAC) inhibitor for cancer. New patient enrollment in the refractory follicular lymphoma cohort of the company's ongoing Phase II clinical trial (Trial 008) is...]]>Sun, 1 Nov 2009 00:00:00 http://www.thefreelibrary.com/QRXPHARMA%2fLIAONING+NUOKANG+MEDICINES+TO+DEVELOP+VENOMICS.-a0210142891
QRxPharma(OTCQX:QRXPY), has announced a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. (Nuokang), a Chinese biopharmaceutical company based in Shenyang, China, to develop and commercialise QRxPharma's venomics assets for the Chinese market. The strategic alliance involves Nuokang investing US$5.0 million for a controlling interest in a Hong Kong company that holds a license...]]>Thu, 1 Oct 2009 00:00:00 http://www.thefreelibrary.com/WYETH'S+TORISEL+APPROVED+BY+EUROPEAN+COMMISSION.-a0208030293
Wyeth Europa Ltd., a division of Wyeth (NYSE: WYE), has announced that the European Commission has approved the mTOR (mammalian target of rapamycin) inhibitor TORISEL(R) (temsirolimus) for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL). In the European Union (EU), TORISEL is also indicated for the first- line treatment of patients with...]]>Thu, 1 Oct 2009 00:00:00 http://www.thefreelibrary.com/PROTALIX+GETS+FDA+FAST+TRACK+DESIGNATION+FOR+PRGCD.-a0208030292
Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for prGCD, the company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.

Fast Track designation is an FDA approved process that facilitates the development and expedites the review...]]>Thu, 1 Oct 2009 00:00:00 http://www.thefreelibrary.com/SANTHERA%2fBIOVAIL+TO+DEVELOP+JP-1730%2fFIPAMEZOLE+IN+AMERICA.-a0208030291
Santhera Pharmaceuticals (SIX: SANN), and Biovail Corporation (NYSE/TSX:BVF) has announced that the two specialty pharmaceutical companies have signed a license agreement for Santhera's JP-1730/fipamezole. Biovail acquires the US and Canadian rights to develop and commercialize the drug for the treatment of Dyskinesia in Parkinson's Disease. JP-1730/ fipamezole is a first-in-class...]]>Thu, 1 Oct 2009 00:00:00 http://www.thefreelibrary.com/BONE+MEDICAL+GETS+US+FDA+GUIDANCE+ON+IND+FOR+CAPSITONIN.-a0208030290
Bone Medical (ASX:BNE) has received a formal response from the US FDA to the IND application filed in June for Capsitonin(tm), its oral formulation of the approved osteoporosis drug salmon calcitonin.

In their response, the FDA has advised that Bone Medical now has an open IND and identifies pathway the company can undertake including a 12-month Phase III study with a...]]>Thu, 1 Oct 2009 00:00:00 http://www.thefreelibrary.com/MALAYSIA+DIAGNOSTICS%2fDEVICES+INDUSTRY+OUTLOOK+FOR+2009.-a0208030289
Nitin Naik, vice president of the Healthcare, Asia Pacific said that the total Healthcare Expenditure grew at 13.70% CAGR from 2003 to 2008, which stood at US$ 7.6 billion in 2008 (up from US$ 4 billion in 2003). Healthcare expenditure in Malaysia is increasing driven by increased privatization within the healthcare service provision and upgrading of existing healthcare...]]>Tue, 1 Sep 2009 00:00:00 http://www.thefreelibrary.com/ORAMED+AWARDED+NIS+3.1+MILLION+GRANT+FROM+ISRAEL.-a0206109125
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, has reported that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant amounting to a total net amount of NIS 3.1 million ($828,000), from the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labor of Israel. This grant was awarded as...]]>Tue, 1 Sep 2009 00:00:00 http://www.thefreelibrary.com/DEBIOPHARM%2fMERCURY+SIGN+LICENSE+AGREEMENT+FOR+DEBIO+0930.-a0206109124
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Mercury Therapeutics, Inc. (Mercury), a privately held biotech company based in Woburn, Massachusetts focusing on the development of novel therapeutics for type 2 diabetes, cancer, and cardiovascular disease,...]]>